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Abstract: Many pharmaceutical products are electroactive and, therefore, can be determined by 
voltammetry. However, most of these substances produce signals in the same region of oxidative 
potentials, which makes it difficult to identify them. In this work, chemometric tools are applied to 
extract characteristic information not only from the peak potential of differential pulse 
voltammograms (DPV), but also from their evolution as a function of pH. The chemometric 
approach is based on principal component analysis (PCA), partial least squares discriminant 
analysis (PLS-DA) and support vector machine discriminant analysis (SVM-DA) yielding promising 
results for the future discrimination of pharmaceutical products in water samples. 
Keywords: pharmaceutical products; differential pulse voltammetry (DPV); electrochemical 
sensors; voltammetric signal evolution with pH; sample discrimination; principal component 
analysis (PCA); partial least squares discriminant analysis (PLS-DA); support vector machine 
discriminant analysis (SVM-DA) 
 
1. Introduction 
In recent years, the increasing use of pharmaceutical products for both clinical and farming 
purposes and the growth of water recycling practices, urged by climate change, have considerably 
raised the presence of such substances and their metabolites in natural waters, wastewaters and food 
products [1–8]. The ecotoxic behavior of many pharmaceutical compounds [9] has led to their 
inclusion in the Watch List of emerging contaminants recently set by EU through the Decision 
2015/495 [10,11]. Thus, the determination of pharmaceutical products in water and food samples is 
of the highest concern. 
This is usually achieved by means of chromatographic techniques, especially liquid 
chromatography combined with fluorescence and mass spectrometric detection [12–15]. These 
techniques are highly selective, sensitive and accurate and allow multianalyte determination. 
However, they are expensive and non-portable and require specifically trained personnel. This is 
why electrochemical sensors, less selective but still sensitive and much simpler, cheaper and portable, 
constitute a promising alternative to chromatography for the screening and monitoring of 
pharmaceutical products [16–18]. Moreover, the recent popularization of commercial screen-printed 
electrodes (SPE) modified with a large diversity of biomolecules and nanomaterials have boosted the 
capabilities of electrochemical sensing in this field [19–22]. 
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Nevertheless, a crucial problem in the electroanalytical detection of a large set of pharmaceutical 
products is that they are reduced or, more frequently, oxidized in similar ranges of potential, which 
depends far more on the nature of the electroactive functional groups than on the structure of the 
molecules. Then, without the support of a previous chromatographic separation, the task of 
simultaneously identifying and quantifying different pharmaceutical products in a sample by 
voltammetry (the most potential-selective electroanalytical technique) is usually restricted to 2 or 3 
substances. For this purpose, bare commercial SPE [23], modified SPE [24,25] and SPE grouped into 
electronic tongues [26] are used and, in the case of overlapping signals, multivariate analysis methods 
are applied [26]. In this scenario, we think that it is highly unrealistic to start a competition between 
SPE sensors and chromatographic methods for the simultaneous determination of dozens of 
pharmaceutical substances in a water sample. A sounder option would be working in two directions: 
on the one hand, modifying SPE with highly selective reagents for the accumulation and 
determination of target compounds (e.g., caffeine or paracetamol) that could act as indicators of 
contamination with pharmaceutical products; on the other hand, developing methodologies for the 
qualitative discrimination among large groups of such substances that could help as preliminary 
screening tools to guide the further analysis by chromatographic methods. The present work lies 
within the second category, quite unexplored up to now. 
It is obvious that the most effective information provided by voltammetry for the qualitative 
identification of substances is the peak potential, which is characteristic of every compound 
independently of its concentration. However, when we think about dozens of compounds, it is sure 
that many of them will have virtually the same peak potential. Then, we could define groups of 
substances with signals appearing in certain potential regions. In this way, the appearance of signals 
in specific potential ranges would reveal the presence of one or more analytes belonging to the group 
of compounds appearing there, whereas the absence of signals would ensure the absence of all of 
them.  
As the single information about peak potentials appears to be clearly insufficient for such an 
ambitious goal, in this work we intend to explore, as a proof of concept, the evolution of peak 
potentials with pH as a new dimension to help in the discrimination of pharmaceutical products. 
Fortunately, protons are involved in the oxidation mechanism of many organic substances and this 
causes a continuous potential shift as pH changes. Indeed, a semi-empirical equation has been used 
to estimate the ratio between the H+-ions and the electrons involved in an electrochemical reaction 
from the slope of peak potential vs. pH plots [27–29]. When voltammetric signals overlap each other, 
chemometric methods are required [30,31], but the potential shifts caused by pH changes produce 
data sets quite far from linearity, which demands specific corrections before the application of 
typically linear methods like principal component analysis (PCA), partial least squares calibration 
(PLS) or multivariate curve resolution by alternating least squares (MCR-ALS) [32–34]. 
In this work we have studied by differential pulse voltammetry (DPV) several mixtures of seven 
characteristic pharmaceutical products that play a crucial role in human life and health:  
(i) Ascorbic acid (AA): a water-soluble vitamin widely used to complement inadequate dietary intake, 
to prevent and treat scurvy and also as antioxidant [35]; (ii) Uric acid (UA): an end product of purine 
metabolism which has been suggested to act as an antioxidant in vivo [36]; (iii) Paracetamol (P): an 
antipyretic and analgesic drug widely used for fever reduction and pain relief associated with 
headache, backache, arthritis and postoperative pain [37]; (iv) Acetylsalicylic acid (AS): a drug of the 
salicylate family used as analgesic, antipyretic and anti-inflammatory; it is also used to treat specific 
inflammatory conditions such as Kawasaki disease, pericarditis and rheumatic fever, and its long-
term use helps prevent further heart attacks, blood clots and ischemic strokes in people with a high 
level of risk [38]; (v) Trimethoprim (TR): an antibiotic used mainly in the treatment of urinary tract 
infections; it has also been used for treatment of acute otitis media caused by Streptococcus pneumoniae 
and Haemophilus influenzae [39]; (vi) Ibuprofen (IB): a nonsteroidal anti-inflammatory drug commonly 
used for the treatment of inflammation, fever and pain caused by migraines, menstrual cramps and 
rheumatoid arthritis [37]; and (vii) Caffeine (C): a central nervous system stimulant that is the most 
commonly used psychoactive substance in the world and whose intakes may protect against some 
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diseases such as Parkinson's disease [37]. Considered mixtures contain five or six of these products 
in the same solution. Voltammetric measurements were made with a commercial screen-printed 
carbon electrode (SPCE) at three concentration levels in solutions of pH ranging from 2 to 12. Then, 
the evolution of the main parameters of the signals (peak current, peak area, half-peak width and, 
especially, peak potential) were studied in order to furnish a feasible strategy to identify the analytes 
from these data. For the exploratory data analysis, PCA was used, whereas different models were 
tested for the discrimination of substances by partial least squares discriminant analysis (PLS-DA) 
and supporting vector machine discriminant analysis (SVM-DA). This last approach is based on the 
supporting vector machine (SVM) methodology, a non-linear strategy that has evolved in the last 
years as a valuable tool for the analysis of non-linear data [40–42]. In light of these results, some 
conclusions are drawn about the perspectives of a future methodology for the qualitative sensing of 
pharmaceutical products mainly in natural waters and wastewaters. 
2. Materials and Methods 
2.1. Chemicals  
Ascorbic acid (AA), uric acid (UA), paracetamol (P), acetylsalicylic acid (AS), trimethoprim (TR), 
ibuprofen (IB), caffeine (C) and boric acid were supplied by Sigma-Aldrich (St. Louis, MO, USA). 
Glacial acetic acid, potassium hydroxide and phosphoric acid were provided by Merck (Darmstadt, 
Germany). Absolute ethanol was purchased from Panreac (Barcelona, Spain). All reagents employed 
were of analytical grade. 
Stock standard solutions of AA, UA, P, AS and C at 10−2 mol L−1 were prepared in ultrapure 
water (Milli-Q plus 185 system, Millipore), whereas 5 × 10−3 and 10−2 mol L−1 stock standard solutions 
of TR and IB, respectively, were prepared in absolute ethanol. All stock solutions were stored at 4 °C 
in the refrigerator safeguarded from light.  
Britton-Robinson (BR) aqueous universal buffer solutions in the pH range of 2–12 consist of a 
mixture of acetic acid, boric acid and phosphoric acid at a concentration of 0.04 mol L−1 each, and 
adjusted to the desired pH with 1 mol L−1 KOH. 
2.2. Apparatus 
For differential pulse voltammetry (DPV) an Autolab System PGSTAT12 (EcoChemie, The 
Netherlands) attached to a VA Stand 663 (Metrohm, Switzerland) was employed. For data acquisition 
a GPES software version 4.9 (EcoChemie) was used. 
The working electrode was a carbon screen-printed electrode (SPCE, 4 mm diameter) provided 
by Metrohm DropSens (Oviedo, Spain) and connected to the Autolab System by means of a flexible 
cable (ref. CAC, Metrohm DropSens). Pt wire auxiliary electrode and Ag/AgCl/KCl (3 mol L−1) 
reference electrode were purchased from Metrohm (Switzerland).  
A Crison micro pH 2000 was used for pH measurements. 
2.3. Voltammetric measurements 
DPV measurements using SPCE were carried out scanning the potential from −0.2 to 1.6 V using 
a pulse time of 50 ms, a pulse amplitude of 100 mV, a step potential of 5 mV, and a scan rate of  
10 mV s−1. All experiments were performed without any oxygen removal. 
DPV measurements of each considered mixture of pharmaceutical products were carried out at 
three concentration levels: 10, 25 and 50 mg L−1, and at twenty pH values ranging from 2 to 12 using 
a different SPCE unit for each pH value assessed. In this sense, it should be mentioned that a SPCE 
unit could be used for a large set of measurements (more than 20), enabling the performance of the 
DPV measurements involved for a single pH value without loss of sensitivity [23]. In addition, every 
new SPCE unit was scanned in a 25 mg L−1 control mixture at pH 5.7 to subsequently correct the 
possible variability derived from the performance of DPV measurements on different days and using 
different SPCE units.  
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2.4. Data treatment 
Characteristic parameters of voltammetric signals (peak potential, peak height, peak area and 
half-peak width) were obtained from experimental voltammograms by means of GPES program by 
Autolab and also by using home-made programs developed for Matlab® environment [43]. In the 
chemometric analysis of data by PCA, PLS-DA and SVM-DA, PLS_Toolbox [44] (a toolbox especially 
designed for Matlab by Eigenvector) was employed. 
3. Results and discussion 
3.1. Preliminary study 
As mentioned in the introduction, seven pharmaceutical products were considered: ascorbic 
acid (AA), uric acid (UA), paracetamol (P), acetylsalicylic acid (AS), trimethoprim (TR), ibuprofen 
(IB) and caffeine (C). Three combinations of these substances were considered with the following 
compositions: (1) AA, P, AS, IB and C; (2) AA, P, AS, TR and C; and 3) AA, UA, P, AS, IB and C. Each 
mixture was measured at the three concentration levels (10, 25 and 50 mg L−1) and at twenty pH 
values ranging from 2 to 12. Figure 1 shows the composition of all three mixtures and the position of 
the corresponding DPV peaks at a concentration and pH value where all signals are visible.  
 
Figure 1. Typical differential pulse voltammograms (DPV) of the three mixtures studied (a–c), which 
contained different combinations of 25 mg L-1 of ascorbic acid (AA), uric acid (UA), paracetamol (P), 
acetylsalicylic acid (AS), trimethoprim (TR), ibuprofen (IB) and caffeine (C) at pH 6.01 (a), 4.55 (b) and 
6.01 (c). 
Figure 2 shows that, as pH increases, all the peaks move to less positive potentials, but the 
potential shift can be quite different. Moreover, there is a general decrease of the peak height at 
extreme pH values. In fact, apart from paracetamol, the signals disappear at too low and, especially, 
too high pH values. As for the baseline, it dramatically increases at alkaline pH, distorting and hiding 
the peaks which appear at the most positive potentials (Figure 2). 
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Figure 2. Evolution of the DPV voltammograms as a function of pH in the mixture of AA, P, AS, TR 
and C at a concentration of 25 mg L−1 of every substance. Baselines have been progressively increased 
for a better view of the signals. The corresponding pH values are shown close to each voltammogram. 
Depending on the pH value, some signals can overlap with each other or with the baseline, but 
most of the time they are reasonably separated. This allowed us to determine the characteristic 
parameters of the signals and study their evolution with pH. From the preliminary study of these 
parameters (not shown) it was clear that only the peak potential exhibited a reproducible variation 
that was very similar at all three concentration levels and in the three mixtures studied, as shown by 
Figure 3. The correction by using the peak potentials measured with every new electrode in a control 
mixture at pH 5.7 slightly increased the reproducibility of peak potentials (differences lower than  
10 mV in most of cases, very low as compared to the evolution of several hundred mV along the pH). 
It was also clear that pH values higher than 9 produced too high baselines and caused the 
disappearance of most of the signals, so that they were discarded for further analysis. 
From Figure 3 it is clear that the evolution of peak potentials with pH is a key parameter that 
can help to discriminate between signals of unknown substances which appear in the same potential 
region. In the next section, PCA, PLS-DA and SVM-DA methods will be applied for this purpose. 
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Figure 3. Evolution of the DPV peak potentials as a function of pH for all the pharmaceutical products 
considered in the three mixtures analyzed (45 peaks in total). The corresponding substances are 
indicated at the right of every series of points. 
3.2. Discrimination of peaks from their evolution with pH 
In order to investigate different discrimination strategies, the peak potentials of the signals were 
organized in a calibration matrix of 30 samples/peaks (in rows) and 14 pH values from 1.94 to 8.76 
(in columns) and a validation matrix of 15 samples (in rows) and 14 pH values (in columns). Every 
set included data from all seven analytes and all three mixtures at different concentrations. 
Concerning data pretreatment, some usual strategies such as mean centering and autoscale were 
tried, but they did not provide good results. Therefore, the original values of peak potentials were 
analyzed without any pretreatment. Only a few values at extreme pH had to be extrapolated by PLS-
Toolbox for these analytes whose peak disappeared under these conditions (e.g., IB). Firstly, PCA 
was used to examine initial patterns in the data. Figure 4 summarizes the results of the application of 
PCA to the calibration and validation sets. A PCA model was successfully built with two principal 
components (PC), the first one (PC1) explaining 99.55% of the data variance and the second one (PC2) 
explaining 0.43% of the variance. The loadings plot (Figure 4c) suggests that the first component 
represents the ‘average’ position of the peak in the potential axis, whereas the second component is 
essentially related to the evolution of the peak potential with pH. When we look at the scores plot 
(Figure 4a) this intuition is confirmed: the substances are ordered along the PC1 axis according to 
their ‘average’ peak potential or, in other words, with the same distribution along the potential axis 
that could be seen in the voltammograms of the mixtures (Figure 1). As for the second component, it 
separates the samples according to the signal evolution with pH being on the upper side of the plot 
with smaller potential shifts (e.g., IB and C) and on the lower side with higher potential shifts (e.g., 
AA, UA and P). Although PC2 is far less important than PC1 in explaining the overall data variance 
(0.43% vs. 99.55%), it is very useful to separate along the vertical axis the scores of the substances 
with similar peak potentials and, hence, very close in the horizontal (PC1) axis (e.g., UA and P or IB 
and TR). As Figure 4a shows, the PCA model of two components allows a reasonable separation of 
the scores corresponding to the seven pharmaceutical products in the calibration set. Additionally, 
the application of the model (i.e., the PCA loadings) to the validation set produced scores for these 
products (Figure 4b) very close to those achieved by the same substances in the calibration step. 
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Figure 4. Results of the principal component analysis (PCA) of the peak potential data as a function 
of pH. The calibration set with 30 peaks/samples at 14 pH values allowed us to build a PCA model 
with two principal components (PC) whose scores (a) and loadings (c) are shown. The application of 
this model to the validation set with 15 peaks/samples at the same 14 pH values produced the scores 
shown in (b). The identification of each sample in the scores plot is made with characteristic colors 
and the corresponding acronyms. 
The PCA of peak potentials allows a qualitative discrimination of substances, but it lacks a 
quantitative estimation of the probability of a peak belonging to a certain substance. This is just what 
PLS-DA can do. Figure 5 shows the results of applying this methodology to the same calibration and 
validation data sets used in PCA. This has been achieved with a set of seven PLS-DA models with 
four latent variables (LV) each. Every calibration model is made by assigning the value of 1 to the 
samples belonging to the class (e.g., peaks of ascorbic acid, AA) and 0 to the samples belonging to 
other predefined classes (i.e., peaks of other substances). As a result, the model predicts a value for 
every sample that, if it is close to 1, means that the sample belongs to the class and, if closer to zero, 
suggests that the sample does not belong to the class. For instance, Figure 5a shows the predictions 
of the AA model for the samples of the calibration set. The values of the AA samples (in red color) 
are quite close to 1, while the other samples are closer to zero. The dashed red line shows the 
threshold value, that clearly separates the samples belonging to the class (above the line) from the 
samples of other classes (below the line). Figure 5b shows the predictions for the AA samples of the 
validation set, which are also very good. In both cases, several parameters can be computed to 
quantify the accuracy of the classification. The most interesting ones are the sensitivity (positive 
samples identified / total positive samples), the specificity (negative samples identified / total 
negative samples) and the classification error (percentage of badly classified samples as compared to 
the total number of samples). The corresponding values for the AA model are 1.0, 1.0 and 0%, which 
are perfect. Table 1 summarizes these and other relevant parameters for the seven substances 
considered.  
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Figure 5. Relevant plots of the partial least squares discriminant analysis (PLS-DA) of the peak 
potential data as a function of pH. Seven PLS-DA models with 4 latent variables (LV) were built with 
the calibration set and yielded class predictions for all seven substances. As an example, (a) and (b) 
show the predictions about the class of ascorbic acid (AA) for the calibration and validation samples, 
respectively. AA samples are denoted in red and the threshold level is shown with a red dashed line. 
(c) and (d) show the class assignation to calibration and validation samples, respectively, according 
to the strict criterion (unassigned samples are denoted with zero). (e) and (f) show the most probable 
class assignation to calibration and validation samples, respectively. 
As it can be seen, not all substances are equally well classified by the PLS-DA models. For 
instance, relatively high classification errors can be found for substances like P, AS or C which may 
have eventual problems of overlapping with the baseline or with neighbor peaks. A good evaluation 
of the overall classification ability of the set of PLS-DA models is the assignment of the samples of a 
data set to the predefined classes. If the strict assignation criterion is used (Figure 5c,d), only the 
samples clearly surpassing the threshold are assigned and, hence, several samples remain 
unassigned. This produces a relatively high overall prediction error (Table 1), especially in the 
validation set (46.7%). In contrast, the assignment of absolutely all the samples to the most probable 
class (Figure 5e,f) produce much better results (0% in the calibration set and 20% in the validation 
set). 
As already pointed out, PLS-DA is a linear method, which means that it is based on the 
hypothesis that all the electroactive substances contribute linearly to the signals. Unfortunately, this 
is not always true in voltammetric measurements. As this could be the source of some weaknesses of 
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the PLS-DA approach, we decided to try a more sophisticated, non-linear method such as SVM-DA, 
also implemented in PLS-Toolbox. Despite its higher complexity, SVM-DA provides results that can 
be visualized in a similar way as before. Thus, Figure 6a,b show the probability that the calibration 
and validation samples belong to the AA class (quite high, in agreement with the high values 
predicted in Figure 5a,b), Figure 6c,d show the ‘strict’ classification and Figure 6e,f show the most 
probable classification of both calibration and validation samples, respectively. 
 
Figure 6. Relevant plots of the support vector machine discriminant analysis (SVM-DA) of the peak 
potential data as a function of pH. The overall SVM-DA model predicts the probability of each sample 
to belong to every predefined class. As an example, (a) and (b) show the predictions about the class 
of ascorbic acid (AA) for the calibration and validation samples, respectively. AA samples are denoted 
in red. (c) and (d) show the class assignation to calibration and validation samples, respectively, 
according to the strict criterion (unassigned samples are denoted with zero). (e) and (f) show the most 
probable class assignation to calibration and validation samples, respectively. 
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Table 1. Summary of the main results obtained in the discrimination of samples by PLS-DA of 4 LV 
and SVM-DA for both the calibration set (Cal.) and the validation set (Val.). The parameters are 
provided for the individual classification of every substance and for the overall classification in both 
strict and most probable modes. 







Sensitivity 1.00 1.00 1.00 0.83 1.00 1.00 1.00 - - 
Specificity 1.00 1.00 0.83 0.79 1.00 1.00 1.00 - - 
Class. error (%) 0.0 0.0 13.3 20.0 0.0 0.0 0.0 26.7 0.0 
RMSEC1 0.167 0.211 0.329 0.316 0.204 0.225 0.257 -  - 
Bias −0.003 0.006 −0.007 0.004 0.001 −0.002 0.002 - - 
R2 0.825 0.285 0.326 0.377 0.329 0.152 0.244 - - 
Val. 
Sensitivity 1.00 1.00 0.67 1.00 1.00 0.00 0.67 - - 
Specificity 1.00 0.93 0.75 0.67 1.00 0.86 0.92 - - 
Class. error (%) 0.00 3.30 26.70 26.70 0.00 20.00 13.30 46.7 20.0 
RMSEP2 0.385 0.226 0.352 0.567 0.203 0.443 0.361  - - 
Bias −0.069 0.023 −0.011 0.072 −0.002 −0.004 −0.009 - - 
R2 0.580 0.207 0.241 0.069 0.005 0.267 0.294  -  - 
SVM-DA 
Cal.  
Sensitivity 1.00 1.00 1.00 1.00 1.00 1.00 1.00 - - 
Specificity 1.00 1.00 1.00 1.00 1.00 1.00 1.00 - - 
Class. error (%) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 
Val.  
Sensitivity 1.00 1.00 1.00 1.00 1.00 1.00 0.67 - -  
Specificity 1.00 1.00 1.00 1.00 1.00 0.93 1.00 - -  
Class. error (%) 0.00 0.00 0.00 0.00 0.00 3.60 16.70 20.0 0.0 
1 Root mean square error of calibration. 2 Root mean square error of prediction. 
The qualitative comparison of the plots in Figures 5 and 6 and, especially, the values of the error 
parameters summarized in Table 1, confirm a significantly better classification when SVM-DA is used 
(0% of error for both calibration and validation samples when the most probable classification is 
used). 
4. Conclusions 
The present work shows that the determination of the peak potentials of DPV signals at different 
pH values using commercial screen-printed electrodes could be used to discriminate unknown 
pharmaceutical products, mainly in natural waters and wastewaters samples but also in food 
products cultivated using reclaimed water, if the data are processed with a chemometric method of 
discriminant analysis. For this purpose, PCA is a convenient exploratory tool, PLS-DA provides a 
reasonable classification and SVM-DA appears to be a very promising strategy for the discrimination 
or even the identification of pharmaceutical products, as it seems to be less affected by the inherent 
non-linearity of voltammetric data.  
Taking into account the large number of pharmaceutical products that are oxidized in the 
potential region considered in this work, it does not seem feasible to univocally identify individual 
substances in real samples by using this methodology. Instead, it seems more convenient to 
determine peak potentials of relevant pharmaceutical products as a function of pH and build an 
extensive database with them. The use of an inner standard like paracetamol (with a clearly visible 
signal even at extreme pH values) could help to minimize the variability of peak potentials due to 
secondary phenomena caused by the presence of other electroactive substances or by matrix effects. 
Then, the database could be used to build discrimination models (PLS-DA or SVM-DA) to stablish 
groups of substances of similar behavior and assign unknown analytes to these groups. The 
application of the model to unknown samples would only require the DPV measurement of the 
sample in the presence of the inner standard at several pH values, which can be achieved with 
successive additions of a KOH solution to the acidic form of the Britton–Robinson buffer.  
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